Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Advances in Radiation Oncology|May 24, 2021
An Evaluation of Health Numeracy among Radiation Therapists and DosimetristsGabrielle W Peters, Jacqueline R Kelly, Jason M Beckta, et al.
Surgical Neurology International|October 23, 2020
Genetic characterization of a case of sellar metastasis from bronchial carcinoid neuroendocrine tumorHong Christopher S, Adam J Kundishora, Aladine A Elsamadicy, et al.
Advances in Radiation Oncology|September 23, 2022
Unsealed Source: Scope of Practice for Radiopharmaceuticals Among United States Radiation OncologistsUtkarsh Shukla, Imran H Chowdhury, Jason M Beckta, et al.
Oncotarget|August 31, 2015
Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joiningJason M Beckta, Seth M Dever, Nisha Gnawali, et al.
ACS Chemical Biology|February 6, 2015
Peptide library approach to uncover phosphomimetic inhibitors of the BRCA1 C-terminal domainE Railey White, Luxin Sun, Zhong Ma, et al.
NPJ Genomic Medicine|June 13, 2020
Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastomaChristopher S Hong, Juan C Vasquez, Adam J Kundishora, et al.
Anticancer Research|June 10, 2019
Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database AnalysisVikram Jairam, Benjamin H Kann, Henry S Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2016
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/SynteninTimothy P Kegelman, Bainan Wu, Swadesh K Das, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiationLaura Biddlestone-Thorpe, Muhammad Sajjad, Elizabeth Rosenberg, et al.
NAR Cancer|December 10, 2021
Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'Sophia Gayle, Robert Aiello, Nalin Leelatian, et al.
Pageof 3